Leadiant Biosciences recalls
Leadiant Biosciences has 4 recalls on record with the FDA and USDA, the earliest in 2018 and the latest reported on 22 Feb 2023. The most frequent reason is sterility.
Total recalls4since 2018
Last 12 months0reported
Class I00% of total
Ongoing0latest 22 Feb 2023
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 25%Class III 3 75%
Why leadiant biosciences is recalled
Product types
By year
All leadiant biosciences recalls, newest first
4 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Abelcet (Amphotericin B Lipid Complex) Injection, 5 mg/mL recalled | Leadiant Biosciences | Sterility | Nationwide |
| Drug | CLASS III | Cystaran (cysteamine ophthalmic solution) recalledCystaran | Leadiant Biosciences | Sterility | PA |
| Drug | CLASS III | Cystaran (cysteamine ophthalmic solution) recalledCystaran | Leadiant Biosciences | Potency & Assay | PA |
| Drug | CLASS III | Cystaran (cysteamine ophthalmic solution) recalledCystaran | Leadiant Biosciences | Potency & Assay | PA |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.